Authors


Megan Seddon, PharmD

Latest:

Staying Ahead of the Curve: Implementing AUC-Guided Vancomycin Dosing

Evidence suggests AUC-guided vancomycin dosing is a safer method than traditional trough-guided dosing.


Jill Murphy

Latest:

NFID Urges Americans to Receive Influenza and Pneumococcal Vaccines

The NFID released data revealing that only 52% of adults in the United States plan to get vaccinated against the flu this season.


Andrew Berti, PharmD

Latest:

Synergy Between Antibiotics and The Innate Immune System

Growing evidence suggests that antimicrobials also interact with host innate immunity to provide potent indirect effects which enhance bacterial clearance and may result in more rapid and complete effects


Jeffrey M. Rybak, PharmD, PhD*

Latest:

Candida auris Is Changing the Paradigm of Antifungal-Resistant Candida

Candida auris is an emerging health care–associated multidrug-resistant fungal pathogen with public health concerns more similar to those of extensively drug-resistant bacterial pathogens than other species of Candida.


Sarah L. Spitznogle, PharmD*

Latest:

Evaluating the Role of New Beta-Lactam Agents for Uncommon Pathogens

Novel β-lactam/β-lactamase inhibitor combinations and cefiderocol may play a part in the treatment of infections caused by Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and Burkholderia cepacia complex.


David R. Ha, PharmD, BCIDP

Latest:

Combination Antifungal for Invasive Mucormycosis: Yay or Nay?

There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.



Jeanne-Claire Fink

Latest:

An NYC Nurse Journals Through the Worst Week of COVID-19

A New York City nurse reflects on "peak-week" in a COVID unit.


Patrick Campbell

Latest:

Anticoagulants Linked to Improved COVID-19 Survival Rate

New data from a New York City-based hospital shows patients on blood thinners had a lower mortality risk due to COVID-19.


Drew Halbur, BSPharm, BCACP, AAHIVP

Latest:

A Pharmacist's Role in HIV Antiretroviral Stewardship in the Hospital

Pharmacists play vital roles in optimizing HIV treatment outcomes in multiple ways and in all medical settings.


Kirk Hevener, PharmD, PhD

Latest:

Study Shows Sulfonamide Antibacterials Capable of Reversing Azole Resistance in Candida albicans

Preliminary studies provide convincing evidence for the synergistic use of sulfonamide agents with azole antifungals.


Rachel Lutz

Latest:

Risk of Venous Thromboembolism (VTE) Low Among Covid-19 Patients

Risk factors for VTE among COVID-19 patients included age greater than 55 years, male gender, a history of thrombophilia, and obesity.


Erin Tuttle, MD

Latest:

Final Diagnosis: Disseminated Kaposi Sarcoma With Tonsillar and Pulmonary Involvement

A shocking find on a CT scan leads to an unexpected diagnosis.


JAMIE L. WAGNER, PHARMD, BCPS

Latest:

Successful Stewardship Strategies in Long-Term Care Facilities

One successful model takes an engineering approach to patient safety outcomes focusing on work system improvements.


Wallace Stephens

Latest:

PrEP: Estimating the Cost-Effectiveness Over 40 Years

Short-term investments in pre-exposure prophylaxis (PrEP) are predicted to result in long-term cost-savings and promote significant health benefits following its distribution in Germany, according to a new modelling study in Eurosurveillance.


Ryan K. Shields, PharmD, MS

Latest:

Is There a Preferred β-Lactam/β-Lactamase Inhibitor Agent for Treatment of KPC-Producing Enterobacterales Infection?

Carbapenem-resistant Enterobacterales present considerable treatment challenges. Recent cumulative evidence supports preference for therapies.


MICHAEL KENT, PHARMD

Latest:

Long-Acting Anti-MRSA Agents: One Dose to Cure?

A review of the current literature and future directions.


MONICA V. MAHONEY, PHARMD, BCPS, AQ-ID

Latest:

Safety of Cefazolin Has Been Underestimated for GBS Prophylaxis During Labor

Both undertreatment and overtreatment were common in this cohort of penicillin-allergic pregnant women with Group B Streptococcus (GBS).


Charitha Gowda, MD, MPH

Latest:

A Closer Look at the Updated WHO HCV Guidelines

Contagion™ Editorial Board member, Charitha Gowda, MD, MPH breaks down the World Health Organization hepatitis C (HCV) guidelines update, and reminds healthcare professionals to build on these guidelines to advocate for the most effective and safest treatment options for our individual patients and all patients worldwide.


Maria Quirch, BSN, RN, OCN

Latest:

Evidence-Based Intervention Reduces C. diff Rates in Adults With Cancer

SMUCLA implements high-touch wipe down intervention to address the need for environmental disinfection of cancer patient care areas.



Kristiana A. Avad, PharmD Candidate

Latest:

Pharmacomicrobiomic Study Shows Significant Gut Bacteria Role in Drug Metabolism and Exposure

A recent study provides what may be the first in-depth examination of the molecular mechanism of biotransformation of a large number of orally administered agents by the human gut microbiota.


ROHAN PARIKH, MD

Latest:

Salt, Ticks, and Lyme: A Case of Lyme Neuroborreliosis Presenting as SIADH

This case report is the fourth documented case of Lyme-induced syndrome of inappro­priate secretion of antidiuretic hormone (SIADH).



Kevin Kunzman

Latest:

COVID-19 or the Flu? Identifying Similarities and Differences

Key signs and symptoms to help distinguish between the 2 respiratory illnesses.


Carole Ellis

Latest:

The Parallels Between Congenital Rubella Syndrome & Congenital Zika Infection

Research presented at the 2017 Annual Pediatric Academic Societies (PAS) meeting examines the similarities between Congenital Rubella Syndrome and Congenital Zika Infection.


DANA BYRNE, MD, MSCE

Latest:

Hospital-Acquired and Ventilator-Associated Pneumonia: Highlights and Pitfalls of the 2016 IDSA / ATS Guidelines

Hospital-acquired and ventilator-associated pneumonia account for 22% of all hospital-acquired infections.


CONAN MACDOUGALL, PHARMD

Latest:

Multidrug-Resistant Pseudomonas aeruginosa Infections: Hard to Treat, But Hope on the Horizon?

Two recently approved agents offer significant activity against these hard-to-treat conditions.


Jessica Burchette, PharmD, BCPS

Latest:

Guidelines to Caring for Patients With Sepsis: Promise or Progress?

Care continues to improve; however, drug-resistant pathogens and a lack of new agents to treat these infections remain a constant challenge.


Khalid Eljaaly, PharmD, MS, BCPS, BCIDP*

Latest:

Changes in Therapy Recommendations in the 2019 ATS/IDSA Guidelines for Community-Acquired Pneumonia

This article highlights some key updates to the antimicrobial therapy recommendations in the updated community-acquired pneumonia guidelines.

© 2023 MJH Life Sciences

All rights reserved.